AANP 2024 WEBINAR: Clinical Research Review of Monoglyceride Omega-3 (MAG-O3): A New Standard in Omega-3 Absorption and Benefits

Tickets

Registrations are closed

AANP 2024 WEBINAR: Clinical Research Review of Monoglyceride Omega-3 (MAG-O3): A New Standard in Omega-3 Absorption and Benefits

Join Us for This Exclusive Dive into MAG-O3 Research

We are excited to invite you to join us for an upcoming webinar as part of the AANP 2024 Webinar Series. This session, Clinical Research Review of Monoglyceride Omega-3 (MAG-O3): A New Standard in Omega-3 Absorption and Benefits, will highlight the groundbreaking research behind MAG-O3 and its superior absorption benefits. Whether you're a healthcare professional or simply passionate about nutrition and wellness, this is a great opportunity to deepen your understanding of the next generation of Omega-3 supplements.

Please register for the event directly on the AANP website by following the link/button above.

We look forward to having you with us!

REGISTER DIRECTLY ON THE AANP WEBSITE

AANP 2024 Webinar Series

Clinical Research Review of Monoglyceride Omega-3 (MAG-O3):

A New Standard in Omega-3 Absorption and Benefits

 

DESCRIPTION

This session delves into the groundbreaking clinical research surrounding Monoglyceride Omega-3 (MAG-O3), showcasing its superior absorption rates and health benefits compared to traditional Omega-3 supplements. Attendees will explore the scientific advancements and clinical evidence that position MAG-O3 as the next generation of Omega-3, setting new standards in nutritional science.


Learning Objectives

  • Understand the unique properties of MAG-O3 that enhance Omega-3 fatty acid absorption
  • Review the clinical research and studies underscoring the effectiveness of MAG-O3.
  • Recognize the potential health benefits of MAG-O3 supplementation in clinical practice.


SPEAKER BIOGRAPHY:

François-Karl Brouillette, M.Sc., Partner and Chief Executive Officer, High 5 Health Group Inc. & EB Supplements

François-Karl Brouillette, M.Sc., with a master's degree in organic chemistry from Université de Montréal, has charted a notable career spanning over two decades in the dietary supplement and natural health product industries. Starting his career in 2001 as a research chemist for a Québec-based pharmaceutical company, he quickly transitioned to the natural health product sector. As the Director of Scientific Affairs and later co-owner of Biodroga, he played a pivotal role in the company’s growth, culminating in its acquisition by Neptune Wellness in 2016. Following this, François-Karl assumed the role of Vice-President of Science and Innovation, where he led the R&D, product development, and strategic supply chain and IP portfolio development.

In his current roles as Partner and CEO of High 5 Health Group Inc. and EB Supplements™, François-Karl leverages his extensive experience in supplement development and formulation to drive the delivery of high-quality, effective products. A respected omega-3 expert with a deep commitment to the industry, his leadership has been instrumental in guiding EB Supplements™ on a path of continued success and innovation. François-Karl's dedication to advancing healthy aging through scientific research and innovative nutrient delivery technology underscores his significant contributions to the field, establishing him as a leading figure in the dietary supplement industry.

 

Samuel Fortin, Ph.D., Partner and Chief Scientific Officer, High 5 Health Group Inc. & EB Supplements

Samuel Fortin, Ph.D. has been at the forefront of omega-3 fatty acid research since earning his Ph.D. in organic chemistry from Université de Sherbrooke in 2003, under the tutelage of Prof. Pierre Deslongchamps. Following his graduation, Dr. Fortin led the natural product chemistry group at the Marine Biotechnology Research Center in Rimouski and served as Associate Professor at Université du Québec in Rimouski. His pioneering work led to the founding of SCF Pharma in 2009, where as President and CEO, he spearheads the development of patented omega-3 monoglycerides MAG-EPA, MAG-DPA, and MAG-DHA.

Beyond his recognized work on omega-3 fatty acids, Dr. Fortin's research interests have expanded to encompass cellular senescence, exploring its implications for health and aging. His pioneering development of the MAG-O3™ technology and his research into cellular senescence exemplify his broad impact on the nutritional sciences field.

With a prolific contribution to scientific literature and a wealth of patents, Dr. Fortin’s work continues to push the boundaries of dietary supplement development. His dedication to enhancing health through scientific innovation has made him a respected voice in the industry, influencing the global dialogue on nutritional supplements and healthy aging.

 

This webinar is approved for 1 General CE by the AANP

Tickets

Registrations are closed
Date & Time
Thursday, October 3, 2024
8:00 PM 9:00 PM (America/Montreal)

Add to Calendar

Location

Hosted by the American Association of Naturopathic Physicians (AANP)

Please register directly on the AANP website by clicking the link provided on the event page.
--Hosted by the American Association of Naturopathic Physicians (AANP)--

Get the direction

Organizer

American Association of Naturopathic Physicians

--American Association of Naturopathic Physicians--
Share

Find out what people see and say about this event, and join the conversation.

Dedicated to Practitioners, Devoted to Science.

Partner with us and unlock your practitioner benefits today!

Become a partner